Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 86 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
851 13.0 months Locally advanced NSCLC 4 Chemotherapy
Radiation
University of Pittsburgh Cancer Institute United States 9/2005
Treatment Details: Patients: This Phase II/III study involved 276 patients with advanced non-small-cell lung cancer who were randomly assigned into three groups. Group A had 91 patients (63 men, 28 women); ei
 
852 13.0 months Stage IIIIB and IV NSCLC 2 Cross Cancer Institute Canada 9/2005
Treatment Details: Patients: This Phase II study involved 171 patients with advanced non-small-cell lung cancer who were randomly assigned into two groups. Group B had 83 patients (43 men, 40 women) with a me
 
853 13.0 months metastatic breast cancer 4 Chemotherapy
Medical Research Council Clinical Trials Unit United Kingdom 11/2005
Treatment Details: Patients: This Phase III study involved 705 women (median age 54) with advanced breast cancer with metastases in bone, liver, lung, lymph nodes, and other tissues. Ninety-five women had rec
 
854 13.0 months Metastatic rcc 4 Immunotherapy
Beth Israel Deaconess Medical Center United States 1/2005
Treatment Details: Patients: This Phase III study involved a total of 192 patients with metastatic renal cell carcinoma. Patients were divided into two groups of 96 patients each. Each group was administered
 
855 13.0 months GBM (newly diagnosed) 3 Chemotherapy
Immunotherapy
Radiation
Surgery
Nihon University School of Medicine Japan 3/2005
Treatment Details: Patients: This trial involved 58 patients: 22 had anaplastic astrocytoma, and 36 had glioblastoma multiforme. Thirty-four patients were men, and twenty-four were women. Overall, the median
 
856 13.0 months Metastatic renal cell carcinoma 4 Immunotherapy
Edward Hines Jr VA Hospital United States 4/2002
Treatment Details: Patients: This Phase II study involved 44 patients with metastatic renal cell carcinoma; 32 men and 12 women. The median age was 56 years. Prior treatments had included nephrectomy (19 pat
 
857 13.0 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Hormone
University of Paris Sud France 11/2011
Treatment Details: Patients: This study involved patients with metastatic castration-resistant prostate cancer who received prior docetaxel-based chemotherapy. The patients were divided into two separate tre
 
858 13.0 months GBM 5 Chemotherapy
Radiation
Harvard Medical School United States 10/2012
Treatment Details: Patients: This phase 2 study involved 20 elderly (over 65) glioblastoma patients. The median patient age was 75.4 years and 9 were male. Treatment: Patients were treated with radiation
 
859 13.0 months Metastatic breast cancer 4 Chemotherapy
Albany Medical Center United States 3/2012
Treatment Details: Patients: This phase 2 study involved women with metastatic breast cancer who were divided into two different patient groups. Group A included 46 patients who had been previously treated w
 
860 13.0 months Advanced NSCLC 4 Biologic therapy
Chemotherapy
Yonsei University College of Medicine Korea 7/2012
Treatment Details: Patients: This phase II study involved patients with advanced non-small-cell lung cancer with no prior chemotherapy who were divided into four separate treatment groups. Group A had 37 pat
 
Page 86 of 187  | Previous Page  | Next Page